17-7549187-CGCCGGGGGGA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_003809.3(TNFSF12):c.41_50delGGGAGCCGGG(p.Gly14fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.000000868 in 1,151,576 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 8.7e-7 ( 0 hom. )
Consequence
TNFSF12
NM_003809.3 frameshift
NM_003809.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.55
Genes affected
TNFSF12 (HGNC:11927): (TNF superfamily member 12) The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. This cytokine, which exists in both membrane-bound and secreted forms, can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Alternative splicing results in multiple transcript variants. Some transcripts skip the last exon of this gene and continue into the second exon of the neighboring TNFSF13 gene; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
TNFSF12-TNFSF13 (HGNC:33537): (TNFSF12-TNFSF13 readthrough) This gene encodes a member of the tumor necrosis factor superfamily. It encodes a hybrid protein composed of the cytoplasmic and transmembrane domains of family member 12 fused to the C-terminal domain of family member 13. The hybrid protein is membrane anchored and presents the receptor-binding domain of family member 13 at the cell surface. It stimulates cycling in T- and B-lymphoma cell lines. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFSF12 | NM_003809.3 | c.41_50delGGGAGCCGGG | p.Gly14fs | frameshift_variant | 1/7 | ENST00000293825.11 | NP_003800.1 | |
TNFSF12-TNFSF13 | NM_172089.4 | c.41_50delGGGAGCCGGG | p.Gly14fs | frameshift_variant | 1/11 | NP_742086.1 | ||
TNFSF12 | NR_037146.2 | n.137_146delGGGAGCCGGG | non_coding_transcript_exon_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFSF12 | ENST00000293825.11 | c.41_50delGGGAGCCGGG | p.Gly14fs | frameshift_variant | 1/7 | 1 | NM_003809.3 | ENSP00000293825.6 | ||
TNFSF12-TNFSF13 | ENST00000293826.4 | c.41_50delGGGAGCCGGG | p.Gly14fs | frameshift_variant | 1/11 | 1 | ENSP00000293826.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 8.68e-7 AC: 1AN: 1151576Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 553246
GnomAD4 exome
AF:
AC:
1
AN:
1151576
Hom.:
AF XY:
AC XY:
0
AN XY:
553246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Common variable immunodeficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2024 | This sequence change creates a premature translational stop signal (p.Gly14Alafs*55) in the TNFSF12 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in TNFSF12 cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TNFSF12-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at